← 홈

HER2+ 유방암

465개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 465개
CGTBiologicstaleChristian HinrichsPhase 1

KK-LC-1 TCR-T cells (KK-LC-1 TCR-T cells)

Gastric Cancer; Breast Cancer · Gastric Cancer

#GastricCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, MK-2206 with or without Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
AntibodystaleMargaret Gatti-MaysPhase 2

Naxitamab (Naxitamab)

Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
ADCBiologicstaleSilverback TherapeuticsPhase 2

SBT6050 (SBT6050)

HER2-positive Breast Cancer; HER2-positive Gastric Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 1%임상시험 2상태 ACTIVE
ADCBiologicstaleJiangsu HengRui Medicine Co., L…Phase 2

SHR-1316 (SHR-1316)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleMarengo Therapeutics, Inc.Phase 2

STAR0602 (STAR0602)

Triple Negative Locally Advanced Non-resectable Breast Cancer; HR+, HER2-, Advanced Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 2상태 RECRUITING
ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

SYS6023 (SYS6023)

Advanced Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
CGTBiologicstaleGuangdong ProCapZoom Bioscience…Phase 1

SZ011 CAR-NK (SZ011 CAR-NK)

Advanced Triple Negative Breast Cancer · Advanced Triple Negative Breast Cancer

#AdvancedTripleNegativeBreastCanc#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 2상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

TQB2102 with TQB2868 (TQB2102 with TQB2868)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
AntibodystaleEli LillyPhase 2

cetuximab, cisplatin (cetuximab, cisplatin)

Head and Neck Cancer · Breast Neoplasm

#BreastNeoplasm#Antibody#Phase2#항체#면역항체+3
효능 ORR 73%임상시험 2상태 ACTIVE
AntibodystaleNeovii BiotechPhase 2

ertumaxomab (ertumaxomab)

Metastatic Breast Cancer; Advanced Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 2상태 DISCONTINUED
ADCBiologicstaleFudan UniversityPhase 2

A1: SHR-A1811 (A1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleJiangsu HengruiPhase 2

A2: SHR-A1811 with Camrelizumab with famitinib (A2: SHR-A1811 with Camrelizumab with famitinib)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicAdcentrx TherapeuticsPhase 1

ADRX-0706 (ADRX-0706)

Solid Tumors; Triple Negative Breast Cancer (TNBC) · Solid Tumors

#SolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
CGTBiologicstaleGuangzhou Anjie Biomedical Tech…Phase 2

AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)

Advanced Breast Cancer; Breast Neoplasm Malignant Female · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
ADCBiologicstaleAlteogen, Inc.Phase 1

HM2-MMAE (ALT-P7, ALT-P7 (HM2-MMAE))

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

trastuzumab (Herceptin, AMG 386 with or without Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

ARX788 + Cemiplimab (ARX788 + Cemiplimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleAlison StopeckPhase 1

durvalumab (Imfinzi, Abemaciclib, durvalumab and aromatase inhibitor)

Breast Cancer Female; Locally Advanced Breast Cancer · Breast Cancer Female

#BreastCancerFemale#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodyBiologicstaleNational Cancer Institute (NCI)Phase 1

Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 ACTIVE

12 / 24 페이지

← 이전다음 →